ArticleFrontiers in immunology2019

BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation.

Bernhard Kerscher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.